Trials / Completed
CompletedNCT03262090
Effect of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery
Efficacy of Different Doses of Dexmedetomidine on the Prevention of Emergence Agitation in Children Undergoing Day Surgery With Desoflurane Anesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 389 (actual)
- Sponsor
- Guangzhou Women and Children's Medical Center · Academic / Other
- Sex
- All
- Age
- 4 Months – 15 Years
- Healthy volunteers
- Not accepted
Summary
Emergence agitation/delirium (EA/ED) is a common complication in pediatric surgery patients, which increases the risk of developing postoperative airway obstruction and respiratory depression. In infants, there is a high incidence of emergence agitation (EA) after desoflurane anesthesia. The aim of the present preliminary study was to determine the safety and efficacy of of intraoperative infusion of dexmedetomidine (DEX) that would prevent postoperative EA and ED in children undergoing day surgery with desoflurane anesthesia
Detailed description
subjects who underwent day surgery were stratified into two age groups as follows: low to 3 years group, and 3-12 years group. Then they were randomly assigned to receive one of six doses of intravenous dexmedetomidine: 0, 0.2, 0.4, 0.6, 0.8 ,1.0ug/kg before skin incision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.2ug/kg dexmedetomidine | subjects were randomly assigned to receive 0.2ug/kg intravenous dexmedetomidine before skin incision |
| DRUG | 0.4ug/kg dexmedetomidine | subjects were randomly assigned to receive 0.4ug/kg intravenous dexmedetomidine before skin incision |
| DRUG | 0.6ug/kg dexmedetomidine | subjects were randomly assigned to receive 0.6ug/kg intravenous dexmedetomidine before skin incision |
| DRUG | 0.8ug/kg dexmedetomidine | subjects were randomly assigned to receive 0.8ug/kg intravenous dexmedetomidine before skin incision |
| DRUG | 1.0ug/kg dexmedetomidine | subjects were randomly assigned to receive 1.0ug/kg intravenous dexmedetomidine before skin incision |
Timeline
- Start date
- 2017-09-18
- Primary completion
- 2019-05-15
- Completion
- 2019-05-21
- First posted
- 2017-08-25
- Last updated
- 2019-06-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03262090. Inclusion in this directory is not an endorsement.